This is a prospective, randomized, double blind, comparative, experimental controlled Phase 3
clinical trial to assess the efficacy, safety and superiority of F0343 (gabapentin combined
with B vitamins) compared to gabapentin alone for treating neuropathic pain in subjects with
chronic distal diabetic polyneuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Merck KGaA Merck KGaA, Darmstadt, Germany
Collaborator:
Merck S.A. de C.V., Mexico
Treatments:
Gabapentin gamma-Aminobutyric Acid Thiamine Vitamin B 12